Medical Properties shares are trading higher after Colliers Securities upgraded the stock to a Buy rating and announced a $6.5 price target. Also, Truist Securities raised its price target from $5 to $6.
Portfolio Pulse from Benzinga Newsdesk
Medical Properties Trust shares rose following an upgrade to a Buy rating by Colliers Securities, with a new price target of $6.5. Truist Securities also increased its price target from $5 to $6.
September 13, 2024 | 2:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medical Properties Trust received a Buy rating from Colliers Securities with a $6.5 price target, and Truist Securities raised its target to $6, boosting investor confidence.
The upgrade to a Buy rating and increased price targets from two securities firms suggest a positive outlook for MPW, likely leading to increased investor interest and a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100